According to a recent meta-analysis, Panax ginseng supplements may help prevent metabolic illnesses by managing blood pressure, glucose, and cholesterol levels in the blood.
 |
| Photo: Panax Ginseng | InStyleHealth |
Twenty-three studies were found in the online databases
PubMed, Web of Science, Embase, and the Cochrane Central Register of Controlled Trials, totaling 27 data sets. All of the studies were randomized controlled
trials, with 20 using a parallel design and three using a crossover design.
After P. ginseng supplementation, the areas under the
curve (AUC) for glucose and insulin were significantly reduced, with reduction
values of 1.77 mmol/Lhr (95 percent confidence interval [CI], –2.97 to –0.57;
p=0.0004) and 101.11 pmol/Lhr (95 percent confidence interval [CI], –160.85 to
–41.38; p=0.0009), respectively.
Other glucose-related indicators, such as fasting
glucose, fasting insulin, 2-hour postprandial glucose, and glycated hemoglobin,
showed no similar alterations.
P. ginseng supplementation also reduced systolic blood
pressure by 3.23 mm Hg (95 percent CI, –4.19 to –2.27; p0.00001), percent body
fat by 2.11 percent (95 percent CI, –3.98 to –0.23; p=0.03), total cholesterol
by 0.17 mmol/L (95 percent CI, –0.28 to –0.05; p=0.005), triglyceride by 0.11 mmol/L
(95 percent CI, –0.21 to –0.01; p=0.03).
"This study has established an academic basis for
P. ginseng supplementation as adjuvant therapy for diabetes, hypertension, and
hyperlipidemia."
Source: J Ginseng Res
2021;doi:10.1016/j.jgr.2021.10.002